OneCell诊断公司筹集了1,600万加元,以扩大美国癌症诊断服务的范围。 OneCell Diagnostics raises $16M to expand cancer diagnostic services in the US.

OneCell Diagnostics 在 Celesta Capital 领投的 A 轮融资中筹集了 1600 万美元，以扩大其在美国的精准肿瘤学服务。 OneCell Diagnostics raised $16 million in a Series A funding round led by Celesta Capital to expand its precision oncology services in the US. 该公司利用先进的液体生物检测技术检测循环肿瘤细胞,为癌症诊断和治疗提供详细的生物标志。 The company uses advanced liquid biopsy technology to detect circulating tumor cells, offering detailed biomarkers for cancer diagnosis and treatment. 资金将帮助推出他们的OncoIndx Ikon测试,使癌症诊断更容易获得,价格更低廉。 Funding will help roll out their OncoIndx Ikon test, making cancer diagnostics more accessible and affordable.